New pharmacological strategies in vascular diseases: a novel intracellular calcium antagonist, HA1077 (AT-877) and cerebral vasospasm
Asano, T.; Hidaka, H.
Methods and Findings in Experimental and Clinical Pharmacology 12(6): 443-448
1990
ISSN/ISBN: 0379-0355 PMID: 2087143 Document Number: 359541
Document emailed within 1 workday
Related Documents
Nishizawa, Y. 1993: The pathogenesis and the preventive treatment of cerebral vasospasm following subarachnoid hemorrhage--especially clinical and pharmacological effect of Ca++ antagonist for vasospasm Nihon Rinsho. Japanese Journal of Clinical Medicine 51 Suppl: 389-396Kyoi, K.; Utsumi, S. 1989: Clinical application of Ca2(+)-antagonist for prevention and treatment of cerebral vasospasm Nihon Rinsho. Japanese Journal of Clinical Medicine 47(8): 1831-1836
Kostiuk, I.F.; Kapustnik, V..A. 2004: Role of intracellular calcium metabolism in vasospasm formation during vibration disease Meditsina Truda i Promyshlennaia Ekologiia 2004(7): 14-18
Wagner, J.A.; Reynolds, I.J.; Snyder, S.H. 1987: Physiological and pharmacological correlates of calcium antagonist receptors Journal of Cardiovascular Pharmacology 10(Suppl 10): S1-S9
Gabay, C.; Porter, B.; Fantuzzi, G.; Arend, W.P. 1998: Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo Journal of Immunology 159(12): 5905-5913
Engelender, S.; De Meis, L. 1996: Pharmacological differentiation between intracellular calcium pump isoforms Molecular Pharmacology 50(5): 1243-1252
Guarneri, L.; Angelico, P.; Ibba, M.; Poggesi, E.; Taddei, C.; Leonardi, A.; Testa, R. 1996: Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine Arzneimittel-Forschung 46(1): 15-24
Zhang, H.-m.; Li, X.; Chang, L.-j.; Zhang, H.-j.; Niu, Q. 2013: Effects of polybrominated diphenyl ether-153 lactation exposure on the concentrations of intracellular calcium ion and calcium-activated related enzymes levels of adult rats' cerebral cortex Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 31(7): 515-518
Niizuma, H.; Kwak, R.; Ohi, T.; Katakura, R.; Mizoi, K.; Suzuki, J. 1978: The angiographical study on cerebral vasospasm following the rupture of intracranial aneurysm (1st report).--Time relationship between vasospasm on angiography and the onset of subarachnoid hemorrhage (aurhor's transl) No Shinkei Geka. Neurological Surgery 6(8): 749-755
Meisheri, K.D.; Humphrey, S.J.; Khan, S.A.; Cipkus-Dubray, L.A.; Smith, M.P.; Jones, A.W. 1993: 4-morpholinecarboximidine-N-1-adamantyl-N'-cyclohexylhydrochloride (U-37883A): pharmacological characterization of a novel antagonist of vascular ATP-sensitive K+ channel openers Journal of Pharmacology and Experimental Therapeutics 266(2): 655-665
Kido, H.; Uchida, Y.; Nakamura, F.; Sugimoto, T. 1990: Angiographic studies on the effects of a novel calcium antagonist AE0047 on cerebral arteries in dogs, with special reference to the preventive effects of AE0047 on cerebral vasoconstriction induced by endothelin Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 95(4): 177-184
Satake, K.; Lee, J.-D.; Shimizu, H.; Uzui, H.; Mitsuke, Y.; Yue, H.; Ueda, T. 2004: Effects of magnesium on prostacyclin synthesis and intracellular free calcium concentration in vascular cells Magnesium Research 17(1): 20-27
Tomera, J.F. 1997: Vascular chemical sulfhydryl alkylation in vitro: alterations in intracellular calcium and cAMP and cGMP metabolism Methods and Findings in Experimental and Clinical Pharmacology 19(2): 113-124
Chen, X.; Yang, Y.; Tao, Y.; Yu, P.; Chen, L. 1998: Alterations of intracellular free calcium concentration of cerebral neuronal cells in infectious brain injury in rats Hunan Yi Ke da Xue Xue Bao 23(4): 353-355
Chiba, A.; Ohta, Y.; Suzuki, T.; Nakanishi, H.; Chichibu, S. 1998: Changes in the gastric vascular network of malignant stroke-prone spontaneously hypertensive rats (M-SHRSP) after administration of the calcium antagonist manidipine Research Communications in Molecular Pathology and Pharmacology 100(2): 151-160
Sakaki, T.; Tanikake, T.; Kyoi, K.; Utsumi, S.; Kikuchi, H.; Oshima, M.; Hiasa, Y.; Murata, Y. 1980: A histopathological study of the brain of patients who died of cerebral vasospasm after rupture of cerebral aneurysm No Shinkei Geka. Neurological Surgery 8(9): 845-850
Kalmykov, M.Iu. 2014: Cerebral artery fenestrations: incidence, association with cerebral arterial aneurysms and other vascular diseases according to the data of multislice spiral computed tomography angiography Vestnik Rentgenologii i Radiologii 2014(2): 21-25
Majchrzak, H.; Lech, A.; Kopera, M.; Gajos, L.; Dragan, T.; Ladziński, P. 1995: Application of alteplase in prevention of cerebral vasospasm and its sequelae in patients after aneurysmal subarachnoid hemorrhage from ruptured cerebral aneurysm Neurologia i Neurochirurgia Polska 29(3): 379-387
Ueda, M.; Masui, M.; Kawakami, M.; Matsunaga, K.; Gemba, T.; Ninomiya, M.; Nakano, A.; Torii, M.; Adachi, I.; Ito, H. 1993: Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 4th communication: prophylactic and therapeutic effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3- b]pyridine-5-carboxylate in stroke-prone spontaneously hypertensive rats Arzneimittel-Forschung 43(12): 1291-1303
Nakajima, M.; Adachi, I.; Ueda, M. 1993: Pharmacological studies on a new Dihydrothienopyridine calcium antagonist. 2nd communication: effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4- (3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate on the 1,4-dihydropyridine binding sites in the brain and on isolated arteries in the Cynomolgus monkey Arzneimittel-Forschung 43(12): 1276-1282